Type 3 resistant starch from Canna edulis reduce lipid levels in patients with mild hyperlipidemia through altering gut microbiome: A double- blind randomized controlled trial
Authors:
Open Access
- 1 June 2024
- journal article
- research article
- Published by Elsevier in Pharmacological Research
- Vol. 205, 107232
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Rotundic acid alleviates hyperlipidemia in rats by regulating lipid metabolism and gut microbiotaPhytotherapy Research, 2023
- High fat diet–induced hyperlipidemia and tissue steatosis in rabbits through modulating ileal microbiotaApplied Microbiology and Biotechnology, 2022
- Statin Eligibility for Primary Prevention of Cardiovascular Disease According to 2021 European Prevention Guidelines Compared With Other International GuidelinesJAMA Cardiology, 2022
- A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic ReceptorsCell, 2020
- GPR146 Deficiency Protects against Hypercholesterolemia and AtherosclerosisCell, 2019
- Reduced Akkermansia muciniphila and Faecalibacterium prausnitzii levels in the gut microbiota of children with allergic asthmaAllergologia et Immunopathologia, 2019
- Association of Long-term Exposure to Ambient Air Pollutants With Risk Factors for Cardiovascular Disease in ChinaJAMA Network Open, 2019
- Dysregulated Microbial Fermentation of Soluble Fiber Induces Cholestatic Liver CancerCell, 2018
- Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis RiskCell, 2016
- The end products of the metabolism of aromatic amino acids by clostridiaArchives of Microbiology, 1976